摘要
目的探讨初发2型糖尿病短期强化胰岛素治疗的安全、有效方法。方法将新入院的60例初发2型糖尿病患者随机分为胰岛素持续皮下注射(CSII)组和胰岛素皮下多次注射(MSII)组,每组30例,观察两组患者治疗前后临床指标变化情况。结果两种方法均可使血糖达标,但CSII组血糖达标时间和胰岛素用量明显少于MSII组(P<0.01),低血糖发生率与MSII组无差异。结论 CSII是一种安全、有效的短期强化胰岛素治疗方法。
Objective To explore the short-term intensive insulin therapy safe, effective methods of the new-onset of type 2 diabetes. Method Sixty new-onset of type 2 diabetes patients who had just been in hospital were randomly divided into continuous subcutaneous insulin injection (CSII) group and subcutaneous injection many times (MSII) group, each of 30 cases. Clinical index changes of two groups of patients before and after treatment were observed. Results Two kinds of method both made blood glucose reach the standard, but the blood glucose and insulin dosage time of CSII group were less than that of MSII group (P 0.01). There was no difference in low blood glucose incidence between them. Conclusion CSII is a safe and effective short-term intensie insulin therapy.
出处
《中国当代医药》
2012年第5期38-39,共2页
China Modern Medicine
关键词
胰岛素持续皮下注射
胰岛素多次皮下注射
初发2型糖尿病
疗效
Continuous subcutaneous insulin injection
Many subcutaneous insulin injection
New-onset of type 2 diabetes
Effect